COMPASS Pathways Investor Relations Material
Latest events
Q1 2024
COMPASS Pathways
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from COMPASS Pathways Plc
Access all reports
COMPASS Pathways plc, a mental health care company, develops psilocybin therapy through bio-pharmaceutical research. The company conducts a clinical trial on the effectiveness of new therapies for depression; and offers COMP360, a formulation of psilocybin for the treatment-resistant depression. It is also developing COMP515, a formulation of psilocybin for Major Depressive Disorder. COMPASS Pathways plc was founded in 2016 and is headquartered in London, the United Kingdom.
Key slides for COMPASS Pathways Plc
Investor Presentation
COMPASS Pathways Plc
Investor Presentation
COMPASS Pathways Plc
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
CMPS
Country
🇺🇸 United States